Genome Therapeutics Ltd
- Small
- Active
- 5 years
- 4 employees
- £1,945,129 (assets)
- Virtual address
- 4 directors
- 2 owners
- Irregular importer
Two conditions of three:
1.Turnover < £10.2 million
2.Balance sheet total < £5.1 million
3.Average number of employees < 50
The owners list was changed 5 months ago, a good sign to sell them something.
Field of Operation
Website
Summary
Genome Therapeutics Ltd, based in London, UK, is a small, active company founded five years ago. With four employees and £1,945,129 in assets, it operates from a virtual address and is overseen by four directors and two owners. The company is an irregular importer of pharmaceutical products, with just one month of imports recorded in May 2023.
The company's website, Genomics Education Programme, serves as a comprehensive resource for genomics education and training within the UK healthcare workforce. It's not an e-commerce site; instead, it provides a wealth of information, courses, podcasts, and resources for health professionals. The site highlights various initiatives, including a Genomics Conversation, competency frameworks, and career resources, all aimed at embedding genomics knowledge across the NHS. The website also features news, events, and videos, and even a glossary of genomics terms.
Financially, Genome Therapeutics Ltd shows some concerning trends. Cash bank on hand has fallen significantly, dropping 55% to £1.5 million. Current assets have also decreased by 45% to £1.9 million, while net assets have plummeted 48% to £1.7 million. While trade debtors have increased by 75%, suggesting potentially delayed payments, creditors have also risen slightly. The company’s small size (meeting two of three conditions for a small company) means it’s likely exempt from an audit, and the figures are unaudited. The increase in bank borrowings by 2400% is a worrying sign, and the description of the company's situation notes the need for additional funding within the next 12 months, creating a material uncertainty.
Registered in England/Wales under the registration number 12392992, with a registered address at SE19 3HF, United Kingdom, London, Regent House, 316 Beulah Hill.
WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.
Owners & PSC
-
Individual
- 5 months
- 25%+
-
Resident of Canada
-
Individual
- 5 years
- 1
- 25%+
-
Resident of United Kingdom
Managers
-
Individual
- 1 year
-
Resident of United Kingdom
-
Individual
- 3 years
-
Resident of United States
-
Individual
- 5 years
- 2
-
Resident of United Kingdom
-
Corporate
- 5 years
- 299
-
Resident of United Kingdom
Last reports
The latest confirmation statement submitted five months ago.
Last news
-
Cancellation of shares. Statement of capital on 2025-01-23Download 6 pages pdf report
-
Purchase of own shares.Download 4 pages pdf report
-
Notification of Samuel Aparicio as a person with significant control on 2025-01-25Download 2 pages pdf report
Importer profile by HS codes
Click on the map to see detailed UK statistics on HS code, including companies list.
Last imported products
Click on items to see detailed UK statistics on HS code, including companies list.
Similar importers
- Company names
- HS codes
- Financial data
- Officers and owners
FAQ about Genome Therapeutics Ltd
Looking for leads in the UK?
Try our FREE App—access UK datasets with limited features!